These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Cerebral blood flow measurements with HMPAO- and HIPDM-SPECT in brain tumors: basic rCBF studies. Maier-Hauff K; Gerlach L; Baerwald R; Cordes M Psychiatry Res; 1989 Sep; 29(3):341-2. PubMed ID: 2608790 [No Abstract] [Full Text] [Related]
3. [A case of meningioma with non-accumulation of 99mTc-ECD and increased accumulation of 99mTc-HMPAO in the tumor]. Kashimada A; Machida K; Honda N; Mamiya T; Takahashi T; Kamano T; Muramatsu M; Inoue Y Kaku Igaku; 1992 Sep; 29(9):1127-31. PubMed ID: 1453563 [TBL] [Abstract][Full Text] [Related]
4. Technetium-99m-HMPAO retention and the role of glutathione: the debate continues. Babich JW J Nucl Med; 1991 Sep; 32(9):1681-3. PubMed ID: 1880568 [No Abstract] [Full Text] [Related]
5. Discordant technetium-99m-MIBI and technetium-99m-HMPAO uptake of recurrent occipital meningioma on brain SPECT images. Shih WJ; Lee JK; Milan P J Nucl Med; 1996 Jul; 37(7):1183-5. PubMed ID: 8965195 [TBL] [Abstract][Full Text] [Related]
6. Discordant technetium-99m HMPAO and thallium-201 chloride distribution in brain tumors. Kamisaki Y; Seto H; Nagayoshi T; Kageyama M; Shimizu M; Wu YW; Watanabe N; Kakishita M Radiat Med; 1996; 14(3):155-8. PubMed ID: 8827811 [TBL] [Abstract][Full Text] [Related]